Home
>
National Drug Code (NDC)
>
Zonisamide
Zonisamide - 0615-1379-39 - (zonisamide)
Drug Information of Zonisamide
| Product NDC: | 0615-1379 |
| Proprietary Name: | Zonisamide |
| Non Proprietary Name: | zonisamide |
| Active Ingredient(s): | 100 mg/1 & nbsp; zonisamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zonisamide
| Product NDC: | 0615-1379 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077637 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121022 |
Package Information of Zonisamide
| Package NDC: | 0615-1379-39 |
| Package Description: | 30 CAPSULE in 1 BLISTER PACK (0615-1379-39) |
NDC Information of Zonisamide
| NDC Code | 0615-1379-39 |
| Proprietary Name | Zonisamide |
| Package Description | 30 CAPSULE in 1 BLISTER PACK (0615-1379-39) |
| Product NDC | 0615-1379 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zonisamide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121022 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | ZONISAMIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
